Literature DB >> 569585

Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. II. Functional investigations of the infiltrating inflammatory cells.

T H Tötterman, P Häyry, E Saksela, T Timonen, B Eklund.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 569585     DOI： 10.1002/eji.1830081209

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


× No keyword cloud information.
  12 in total

1.  Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma: cytotoxicity, growth kinetics and phenotype.

Authors:  E Lotzová; C A Savary; R S Freedman; C L Edwards; M Morris
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.

Authors:  M Radrizzani; C Gambacorti-Passerini; G Parmiani; G Fossati
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Lymphoreticular infiltrates in invasive ductal breast cancer. A histological and immunohistological study.

Authors:  H P Horny; H A Horst
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Modification of natural killer activity of lymphocytes infiltrating human lung cancers.

Authors:  T M Anderson; Y Ibayashi; E C Holmes; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

5.  Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancer.

Authors:  S B Hosch; A J Meyer; C Schneider; N Stoecklein; K L Prenzel; K Pantel; C E Broelsch; J R Izbicki
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

6.  The effect of lymphocytic infiltration on clinical survival in cancer of the tongue.

Authors:  T Sarioğlu; T Yilmaz; A Sungur; B Gürsel
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

7.  Activated lymphocyte killer cells derived from melanoma tissue or peripheral blood.

Authors:  G F Burns; M F Good; C Riglar; P F Bartlett; R M Crapper; I R Mackay
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

Review 8.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

9.  In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trial.

Authors:  J S Economou; A S Belldegrun; J Glaspy; E M Toloza; R Figlin; J Hobbs; N Meldon; R Kaboo; C L Tso; A Miller; R Lau; W McBride; R C Moen
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

Review 10.  Natural killer cells in human solid tumors.

Authors:  M Introna; A Mantovani
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.